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Valvuloseptal morphogenesis of the primitive heart tube into a four-chambered organ requires the formation of endocardial
cushion tissue. The latter is the outcome of an inductive interaction in which endocardial (endothelial) cells are induced
to transform into mesenchyme by paracrine signals secreted by the adjacent myocardium. In this study, we propose that
transforming endothelial/mesenchymal cells themselves secrete a factorÐTGFb-3Ðthat functions in an autocrine mode
to promote/sustain mesenchyme formation and possibly in a paracrine manner to amplify the original (myocardial) induc-
tive event. Cushion mesenchyme-conditioned medium, previously demonstrated to be an endogenous source of autocrine,
migration-promoting factors, was found in the present study to contain TGFb-3, as detected by immunoblot analysis.
Immunoneutralization of TGFb-3 in preparations of cushion mesenchyme-conditioned medium resulted in a failure of
treated target endocardial cells to migrate as mesenchyme, whereas inclusion of a control antibody did not inhibit the
migration-promoting activity of the conditioned medium. Similar to treatment with the conditioned medium, direct
addition of TGFb-3 to target endocardial cells also elicited invasive migration but only in cultures which had been activated
in vivo by inductive interaction with the myocardium prior to treatment. Selective inhibition of TGFb-3-mediated autocrine
signaling in continuous cocultures of endocardium plus myocardium resulted in endocardial cells which did not migrate,
even though they had expressed early markers associated with endocardial cell activation (e.g., a-smooth muscle actin,
ES/130, and TGFb-3). Collectively, these results suggest that (i) two signaling pathways, myocardial and endocardial, are
required to start and complete epithelial±mesenchymal transformation in cushion-forming regions of the heart and (ii) the
endocardial pathway signals through iteration of TGFb-3 and is not functionally redundant to the myocardial pathway.
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INTRODUCTION Similar to epithelial±mesenchymal transformations
occurring in other systems, formation of endocardial
cushion tissue is a multistep process of speci®c morpho-Epithelial±mesenchymal transformations are fundamen-
logical and biochemical modi®cations of cells as they ac-tal to differentiation and organogenesis in the vertebrate
quire a mesenchymal phenotype (Hay, 1995). Precedingembryo (Hay, 1996). Such transformations are particularly
the formation of endocardial cushion tissue in the chickprevalent in the morphogenesis of the heart (Markwald et
(i.e., HH stages 10±14; Hamburger and Hamilton, 1951),al., 1996). The generation of endocardial cushion tissue, the
the primitive heart tube consists of two concentricallypresumptive valvuloseptal tissue of the embryonic heart,
arranged epitheliaÐthe myocardium and the endocar-represents one of the best-characterized systems of epithe-
diumÐseparated by cardiac jelly, an expansive extracel-lial±mesenchymal transformation of cells within a cardiac
lular matrix which constitutes the myocardial basementlineage (Eisenberg and Markwald, 1995; Markwald et al.,
membrane (MBM)2 (Kitten et al., 1987). Beginning at stage1996).
15, endocardial cells positioned speci®cally within the
2 Abbreviations used: AV, atrioventricular; MCCM, mesen-1 Current address: Cardiovascular Research Center, Massachu-
setts General Hospital, Harvard Medical School, Charlestown, MA chyme-conditioned medium; MBM, myocardial basement mem-
brane; OT, out¯ow tract; TGFb, transforming growth factor beta.02129.
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atrioventricular (AV) and conotruncal regions of the endo- treated cultures and to abolish the ability of endocardial/
mesenchymal-conditioned medium to signal new mesen-cardium progressively transform from an epithelial to a
migratory mesenchymal cell phenotype (Kinsella and chyme formation in companion control cultures. Reversal
(rescue) of inhibitory effects of the antibodies was possibleFitzharris, 1979; Markwald et al., 1984; Icardo, 1989). The
earliest morphological signs of the transformation pro- if TGFb ligands were added directly to culture media. To-
gether, these results suggest that a myocardial (paracrine)cess have been called ``activation'' (Bolender and Mark-
wald, 1979; Markwald and Funderburg, 1983) and include pathway and an endocardial (autocrine/paracrine) pathway
may combine to initiate and complete transformation ofhypertrophy and loss of uniform cell shape, detachment
from one another, and extension of elongated cell pro- endocardial cells into cushion mesenchyme.
cesses into the adjoining extracellular matrix (Markwald
et al., 1975; Bolender and Markwald, 1979; Icardo, 1989).
Subsequently, a subset of activated cells then completely MATERIALS AND METHODS
detaches from the endocardial tube and migrates into the
adjacent MBM (Markwald et al., 1975; Wunsch et al., Epithelial±mesenchymal bioassay. Fertilized chicken eggs
1994). Endocardially derived cells which invade the MBM were obtained from a local hatchery (PeeDee Hatchery, Hartsville,
are otherwise known as cushion mesenchyme and the SC) and incubated at 377C and 60% humidity to achieve desired
stages. Embryos were carefully staged according to criteria of Ham-entire population of such cells constitutes the endocardial
burger and Hamilton (1951). Hearts were removed from embryoscushion tissue.
under sterile conditions, and AV explants containing myocardiumIt is generally accepted that the process of endocardial cell
and endocardium were established as described previously (Ber-transformation is mediated by inductive factors secreted
nanke and Markwald, 1982; Runyan and Markwald, 1983). Forby the myocardium (Krug et al., 1985, 1987). The current
some experiments, myocardial tissue was removed 4±6 hr follow-paradigm is that epithelial±mesenchymal transformation is
ing placement of the explants into culture. At this time remaining
initially elicited by regionally restricted, inductive factors endocardial monolayers were extensively rinsed with serum-free
secreted by the AV and conotruncal myocardium before the medium M199 (Gibco) and then treated with freshly harvested mes-
endocardium visibly begins its transformation (Krug et al., enchyme-conditioned medium (MCCM, described below); MCCM
1987; Mjaatvedt and Markwald, 1989). These paracrine-act- containing 100 mg/ml nonimmune goat IgG (Chemicon) or 100 mg/
ml goat anti-TGFb-3 neutralizing grade antibody (R&D Systems);ing factors are detectable in the stage 14 MBM and in EDTA
M199 supplemented with 1% chick serum (Spafas) plus 5 mg/mlextracts of the MBM as adheron-like particulates (Mjaatvedt
insulin, 5 ng/ml selenium, and 5 mg/ml transferrin premix (Sigma)and Markwald, 1989) which contain ®bronectin, proteins
(complete M199); or complete M199 supplemented with 10 ng/with af®nity for soybean agglutin (Sinning et al., 1995),
ml recombinant chicken TGFb-3 (R&D Systems). In accord withand antigens recognized by antibodies (ES antibodies) that
previous use of this assay (Potts and Runyan, 1989) promotion ofblock cushion mesenchyme formation in culture assays
mesenchyme formation was evaluated in endocardial monolayers
(Mjaatvedt et al., 1991; Isokawa et al., 1994; Rezaee et al., following 48 hr of treatment. Data for all experiments were ana-
1993). Recently, however, in response to paracrine myocar- lyzed by a x2 test, since it is percentages of cultures which contain
dial signaling, the transforming endocardial/mesenchymal invasive cells that are being compared.
cells themselves were found to secrete a factor(s) into its For inhibition experiments, explants containing AV myocardium
plus endocardium were established from stage 13/ and stage 14growth medium which induced, in turn, invasive mesen-
hearts, rinsed following 6±8 hr of incubation, and treated withchyme formation when applied to control, endocardial
complete medium 199 supplemented with either 100 mg/ml nonim-monolayers which otherwise would not have done so under
mune goat IgG or 100 mg/ml goat anti-TGFb-3 neutralizing anti-the given experimental conditions (Ramsdell et al., submit-
body or with complete M199 supplemented with both 100 mg/mlted). One likely candidate for this endothelial/mesenchy-
goat anti-TGFb-3 neutralizing antibody and 10 ng/ml recombinantmal-derived factor is a TGFb growth factor. Changes in
chicken TGFb-3. AV cocultures were evaluated following 24 hr of
TGFb expression occur in endothelial cells and their mesen- treatment, and data for all experiments was analyzed by a x2 test,
chymal progeny which correlate with the onset of cushion since it is percentages of cultures which contain invasive cells that
formation (Akhurst et al., 1990; Nakajima et al., 1994). The are being compared.
expression of type II TGFb receptors on these cells in vivo Preparation of mesenchyme-conditioned medium. AV cushion
pads (containing endocardially derived mesenchymal cells, sur-(Brown et al., 1996) suggests the secreted growth factor
rounding extracellular matrix, plus a single-cell layer of endocardialcould function as an autocrine signaling mechanism acti-
sheath) were dissected from Day 4 whole hearts (stages 19±24)vated in response to myocardial induction. Thus, the objec-
and carefully isolated from the adjacent myocardial wall. Cushionstive of the present study was to test the hypothesis that
devoid of myocardial walls were then rinsed with cold Earle's bal-TGFb is secreted by endothelial cells that are previously
anced salt solution (EBSS; pH 7.2; Gibco) and brie¯y dispersed withactivated by myocardial signaling in order to promote, sus-
0.25% pancreatic trypsin (Gibco) in EBSS and cultured overnight
tain, or even amplify their transformation into cushion mes- in complete medium. The next day, cultures were extensively
enchymal cells. Results obtained using both puri®ed TGFb- rinsed with serum-free M199 and incubated in fresh complete
3 polypeptide and TGFb-3 antibody indicate that TGFb-3 is M199. The resulting conditioned medium was harvested and clari-
an endocardially expressed factor whose selective inhibition ®ed by centrifugation at 1000g just prior to use.
Immuno¯uorescent labeling of endocardial cell cultures. Cul-was suf®cient to arrest mesenchyme formation within
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tures were ®xed and immuno¯uorescently stained as described 14, endocardial monolayers cultured without myocardium
(Nakajima et al., 1994). Antisera used in this study were a-smooth and treated with standard control medium remained as epi-
muscle actin mouse ascites ¯uid, diluted 1/200 (Sigma), and rabbit thelial-like sheets of cells and did not show evidence of
anti-TGFb-3 used 10 mg/ml (Santa Cruz). For dual labeling, cultures cell migration or invasion into the gel (Figs. 1A and 1B).
were processed as described except primary antibodies were incu- In contrast, variable numbers of cultures from either stage
bated simultaneously, followed by rinsing and simultaneous addi-
responded to TGFb-3 by forming mesenchyme. However, ation of goat anti-mouse IgG and goat anti-rabbit IgG (Organon Tek-
statistically signi®cant difference was noted between thenika Corp.). Speci®c staining was determined by comparison to
two stages: at stage 13/, 40±45% on average of the endocar-cultures incubated with nonimmune mouse IgG (Organon Teknika
dial cultures were able to form mesenchymal cells (aboveCorp.) in place of primary antibody plus rabbit anti-TGFb-3 which
had been preadsorbed with a 10-fold excess (w/w) of TGFb-3 peptide background levels) compared to nearly 75% at stage 14.
(Santa Cruz). We chose to report the percentage of cultures from a given
For ES/130 immunostaining, culture were ®xed with ice-cold treatment group that had formed mesenchyme rather than
methanol, rehydrated with PBS, and processed as above with 20 counting the total number of mesenchymal cells in all the
mg/ml immunogen-af®nity puri®ed rabbit anti-ES/130 peptide II explants combined for that particular treatment (Fig. 2). The
(Ramsdell et al., submitted). Controls included substitution of non- rationale for this was that for any given explant (control or
immune rabbit IgG (20 mg/ml; Organon Tenika Corp.) for primary
experimental) the number of mesenchymal cells that hadantibody and preadsorption of rabbit anti-ES/130 peptide II with a
been formed could vary from 0 to 100/ owing in part to (i)10-fold excess (w/w) of ES/130 peptide II (Ramsdell et al., submit-
technical dif®culties in obtaining explants of the exact sameted) prior to incubation with cultures.
size and position within the AV canal and (ii) the inherentImmunoblot analysis of MCCM. Clari®ed conditioned me-
dium (800 ml) was applied to an Ultrafree centrifugal ®ltration unit differences between the capacity of the superior and inferior
(10,000 MW cutoff; Millipore) at 47C. Both the resulting concen- AV cushions to initiate mesenchyme formation (Moreno et
trate and the 10-ng samples of recombinantly expressed chicken al., 1997). Thus, based on relative frequencies of cultures
TGFb-3 (R&D Systems) were boiled in sample buffer prior to 12% to form mesenchyme, TGFb-3 was a potent inductive stim-
SDS±PAGE and electrophoretic transfer to Immobilon (Schleicher ulus for endocardial cell transformation into mesenchyme.
and Schuell) as described (Rezaee et al., 1993). Blots were incubated This was particularly evident in endocardial monolayers
with 2 mg/ml rabbit anti-TGFb-3 (Santa Cruz), followed by biotinyl-
established from older, stage 14 hearts (in which the major-ated goat anti-rabbit IgG (1/4000; Bio-Rad), and immunoreactive
ity of endocardial cells had been previously activated inproteins were detected with a streptavidin±horseradish peroxidase
vivo by the myocardiumÐRamsdell et al., submitted).(HRP) conjugate (Amersham; 1/4000) and an HRP chemilumines-
cent substrate (ECL kit; Amersham) according to manufacturer's
speci®cations. Control blots were incubated with rabbit anti-
TGFb-3 that had been preadsorbed with a 10-fold excess (w/w) of Detection of TGFb-3-Immunoreactive Protein in
TGFb-3 peptide (Santa Cruz) and then processed as described above. Mesenchyme-Conditioned Medium
The increased incidence of mesenchyme formation in re-
sponse to TGFb-3 was statistically similar to results re-RESULTS
cently obtained for similar stages using medium condi-
tioned by transforming endocardial/mesenchymal cells andExogenous TGFb-3 Promotes Migration/Invasion of
referred to as mesenchymal cell conditioned mediumAV Endocardial Cells
(Ramsdell et al., submitted). Thus, we next sought to deter-
mine whether TGFb-3 was a component of MCCM andPrior immunohistochemical analysis in chick hearts indi-
cated that TGFb-3 was expressed in target endocardial cells therefore a protein secreted by transforming cushion cells
in vitro as suggested by in vivo immunostaining (Nakajimain response to myocardial induction. Accordingly, it was
hypothesized that endocardial cells, upon activation by et al., 1994). Endocardial cushion tissue (endocardium /
mesenchyme) was enzymatically dispersed and maintainedmyocardial signaling, secreted TGFb-3 as part of an in vivo
autocrine mechanism for regulating the transformation in culture to produce a mesenchymal cell condition me-
dium which was examined for the presence of TGFb-3 pro-from endocardial to mesenchymal phenotype (Nakajima et
al., 1994; Ghosh and Brauer, 1996; Ramsdell et al., submit- tein by immunoblot analysis. As shown in Fig. 3, MCCM
contains TGFb-3-immunoreactive proteins, as evidenced byted). To pursue this hypothesis, recombinant, chick TGFb-
3 polypeptide was tested for its potential to elicit mesen- detection of bands that comigrated with those detected in
samples of recombinant chicken TGFb-3 under reducingchyme formation using HH stage 13/ vs HH stage 14 AV
endocardial monolayers growing on collagen gel lattices. conditions (lanes 1 and 2), and which were not detected in
samples probed with a TGFb-3 peptide-preadsorbed anti-One signi®cance of selecting these two particular stages is
that previous in vivo studies have shown that while visible body (lanes 3 and 4). The 12.5-kDa bands correspond to
a proteolytically processed form of TGFb, and the higherevidence of invasive migration does not occur until stage
15, the majority of stage 14 but not stage 13 endocardial molecular weight bands represent latent forms of TGFb.
These ®ndings indicate that TGFb-3 protein is present incells have already received a myocardial activation signal
(Ramsdell et al., submitted). At either stage 13/ or stage MCCM and is therefore available as a potential candidate to
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FIG. 1. Exogenous TGFb-3 promotes invasive mesenchyme formation in activated AV endocardial cultures. Stage 14 AV endocardial
monolayers cultured in the absence of myocardial tissue and treated with control medium M199 typically do not form invasive mesenchyme
[(A) surface view, (B) deep view]. Stage 14 AV endocardial monolayers treated with M199 supplemented with 10 ng/ml recombinant
chicken TGFb-3 give rise to formation of invasive mesenchyme (arrowheads) which are detected beneath the plane of the monolayer [(C)
surface view, (D) deep view]. Bar, 100 mm.
modulate the mesenchyme-promoting activity associated the majority of cultures treated with MCCM alone (data
not shown) or MCCM plus the control (nonimmune IgG)with the MCCM.
antibody (Figs. 4A and 4B). However, inclusion of an anti-
body speci®c for the TGFb-3 isoform antagonized the
TGFb-3 Antibodies Antagonize the Mesenchyme- mesenchyme-promoting activity of the MCCM (Figs. 4C
Promoting Activity of Mesenchyme-Conditioned and 4D). As summarized in Fig. 5, about 75% of the stage
Medium 14 cultures treated with MCCM plus control antibody
contained invasive mesenchyme, compared to about 10%As indicated above, treatment with TGFb-3 produced
of cultures treated with MCCM plus the TGFb-3 anti-results similar to those previously reported for MCCM
body. Stage 14 cultures that had been treated with eitherwhen applied to HH stage 13/ vs HH stage 14 AV endo-
the control IgG antibody or anti-TGFb-3 antibodies alsocardial cell monolayers. Thus, to determine whether it
were examined for the expression of in vivo markers ofwas the presence of TGFb-3 within MCCM that was act-
the activated endocardial phenotype [ES130 (Rezeae et al.,ing as the bioactive signal for mesenchyme formation,
1995), a-smooth muscle actin (Nakajima et al., 1997) orwe treated HH stage 14 AV endocardial monolayers with
TGFb-3 itself (Nakajima et al., 1994). ImmunoabsorptionMCCM containing either an antibody speci®c for the
of TGFb from MCCM did not decrease or inhibit expres-TGFb-3 isoform or a nonimmune IgG control antibody
(Fig. 4). Formation of invasive mesenchyme occurred in sion of any of the early activation markers compared to
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associated myocardium results in mesenchyme formation
after 24 hr in nearly each instance (Bernanke and Markwald,
1982; Runyan and Markwald, 1983). Similar results were
obtained in the present study for both HH stages 13/ and
14 as evidenced by cells that invaded the collagen gels (Figs.
7 and 8). Inclusion of a nonimmune control IgG antibody
did not inhibit this process (Figs. 7A, 7B, and 8). However,
addition of a TGFb-3 antibody to continuous cocultures of
endocardium and myocardium from either HH stage 13/
or HH stage 14 inhibited both the outgrowth of endocardial
cells on the surface of the gels and the invasion of cells
into the gels (Figs. 7C and 7D). Mesenchyme formation was
signi®cantly restored in both stage 13/ (data not shown)FIG. 2. Quantitative summary of mesenchyme formation in
TGFb-3-treated AV endocardial cultures. Stages 13/ and 14 target and stage 14 hearts by the simultaneous inclusion of excess
AV endocardial monolayers were cultured in the absence of myo- TGFb-3 polypeptide growth factor (Figs. 7E and 7F). The
cardial tissue and treated with control medium M199 or M199 results obtained using either the control or the TGFb-3 anti-
supplemented with 10 ng/ml recombinant chicken TGFb-3. Cul- bodies are summarized quantitatively in Fig. 8. As with
tures were scored positive for mesenchyme formation based on ®ndings obtained with MCCM, adding anti-TGFb-3 anti-
detection of more than three cells beneath the plane of the ex-
bodies to cocultures of endocardium and myocardium in-planted monolayer. The results are expressed as averages {SD and
hibited mesenchyme formation but it did not suppress ex-were signi®cantly different as evaluated by a x2 test for proportions
pression of markers associated with endocardial activation(x2  19.76, P  0.00001 for stage 13/; x2  21.53, P  0.00001
(Fig. 9). Similar to IgG control antibody-treated cultures (Fig.for stage 14). Stage 13/, n  19 (M199), n  19 (M199 / TGFb-3).
9A), HH stage 13/ endocardial cells present in TGFb-3 anti-Stage 14, n  27 (M199), n  27 (M199 / TGFb-3).
body-treated cultures expressed a-smooth muscle actin and
TGFb-3 (Fig. 9B) and ES/130 protein (not shown), indicating,
again, that even though the TGFb-3 antibody-treated cells
had failed to migrate, many of them had still undergone theMCCM treated with control antibody (Fig. 6). This indi-
cates that even though endocardial cells were inhibited initial steps of transformation, or activation. Similar results
were obtained using HH stage 14 AV cocultures (data notfrom forming mesenchyme in response to MCCM by the
addition of anti-TGFb-3 antibodies, expression of early shown).
Together, these ®ndings suggest that endocardially-ex-activation markers including TGBb-3 itself was not.
pressed TGFb-3 is required to sustain endocardial cell trans-
formation in vitro, and that under conditions in which such
Immunoneutralization of TGFb-3 Is Also Suf®cient
to Inhibit Transformation of AV Endocardial Cells
Cocultured with Associated Myocardial Tissue
It was next examined whether the TGFb-3 secreted into
MCCM by transforming endocardium/mesenchyme is actu-
ally an autocrine mechanism needed to sustain or complete
transformation of AV endocardium cultured in the presence
of the myocardium. In other words, is the autocrine secre-
tion of TGF by transforming cushion cells merely redundant
to a paracrine myocardial signaling pathway which alone
could support complete transformation? The presence of
TGFb-3 in MCCM indicates that this growth factor is se-
creted by cushion-forming cells, whereas no evidence cur-
rently exists for the presence of activated TGFb-3 in the
FIG. 3. Detection of TGFb-3-immunoreactive proteins in mesen-acellular myocardial basement membrane (cardiac jelly)
chyme-conditioned medium. Western analysis of mesenchyme-that separates endocardium and myocardium prior to mes-
conditioned medium (lane 2) reveals immunoreactive bands whichenchyme formation (Nakajima et al., 1994). Thus, assuming
comigrate with bands detected in samples of recombinant chickenthe myocardium does not secrete any immunologically de-
TGFb-3 polypeptide under reducing conditions (lane 1). The 12.5-tectable TGFb-3, the use of a TGFb-3 antibody in cocultures
kDa bands represent the proteolytically processed form of TGFb-
of myocardial and endocardial tissue would be expected to 3, whereas the higher molecular weight bands correspond to latent
primarily affect the endocardial/mesenchymal signaling forms of TGFb-3. Immunoreactive proteins present in samples of
pathway. recombinant chicken TGFb-3 (lane 3) and in mesenchyme-condi-
As has been historically and repeatedly shown, continu- tioned medium (lane 4) are less detectable with a TGFb-3 peptide-
preadsorbed antibody.ous coculture of HH stage 14 AV endocardium with the
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FIG. 4. Immunoneutralization of TGFb-3 in mesenchyme-conditioned medium. Treatment of stage 14 target AV endocardial monolayers
with MCCM plus polyclonal goat anti-TGFb-3 IgG does not induce formation of invasive mesenchyme [(C) surface view, (D) deep view].
In contrast, inclusion of nonimmune goat IgG results in formation of invasive mesenchyme (arrowheads) which are detected beneath the
plane of the monolayer [(A) surface view, (B) deep view]. Bar, 100 mm.
autocrine signaling is inhibited, the paracrine myocardial DISCUSSION
pathway by itself is not suf®cient to support and complete
the transformation process. Runyan and his colleagues (Potts and Runyan, 1989; Potts
et al., 1991; Runyan et al., 1992; Huang et al., 1995) were
the ®rst to recognize that exogenous and endogenous TGFb
could promote the process by which cultured endocardial
cells of speci®c heart regions transformed into cushion mes-
enchyme. However, the mechanism by which TGFb func-
tions in this system has remained unde®ned, largely be-
cause panspeci®c antibodies and antisense deoxyoligo-
nucleotides directed against speci®c TGFb isoforms (Potts
and Runyan, 1989; Potts et al., 1991, 1992; Ghosh and
Brauer, 1996) or TGFb type II receptor (Brown et al., 1996)
were applied to continuous cocultures of AV endocardium
and myocardium. As a result, key important, unresolved
questions include (1) do exogenously added TGFb ligands
promote mesenchyme formation by directly affecting the
FIG. 5. Quantitative summary of TGFb-3 immunoneutralization endocardium or the myocardium, (2) which TGFb iso-
studies. Stage 14 AV endocardial cells were treated with MCCM form(s) is required for regulating cushion formation, and
plus either control or TGFb-3 antibody and evaluated for the pres- (3) is endogenously secreted TGFb functioning as a signal
ence of invasive (seeded) mesenchyme following 48 hr of treatment. derived from the myocardium, the endocardium, or both.
Cultures were scored positive for mesenchyme formation based on
The present study demonstrates for the ®rst time thatdetection of at least three cells beneath the plane of the explanted
TGFb can directly affect the fate of AV endocardial cells.monolayer. The results are expressed as averages {SD and were
Embryonic AV endocardial cells responded to TGFb-3 bysigni®cantly different as evaluated by a x2 test for proportions (x2
migrating (invading) into a collagen gel lattice. However, 25.93, P  0.000001). Stage 14, n  30 (MCCM / nonimmune
IgG), n  25 (MCCM / TGFb-3 antibody). we found that the majority of endocardial cells did so only if
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FIG. 6. Expression of early activation markers of epithelial mesenchymal transformation are detected in AV endocardial cells treated
with mesenchyme-conditioned medium plus control or TGFb-3 antibodies. Stage 14 AV endocardial monolayers were treated with
mesenchyme-conditioned medium plus control (A, B) or TGFb-3 (C, D) antibodies as described for Fig. 4. After 24 hr of treatment, cultures
were immuno¯uorescently labeled with rabbit anti-ES/130 (A, C) or dual labeled with monoclonal anti-a-smooth muscle actin (B, D;
FITC) and rabbit anti-TGFb-3 (B, D; RITC). Detection of these protein markers was similar between treatment groups, and orange-yellow
staining is indicative of colocalized immunoreactivity in the dual-labeled cultures (B, D). Bar, 100 mm.
they were explanted from stage 14 embryos. AV endocardial initiate endocardial cell transformation in vitro (Mjaatvedt
and Markwald, 1989; Nakajima et al., 1994). Second, it hascells from embryos only 8 hr younger (stage 13) consistently
failed to respond to TGFb-3, suggesting a temporal correla- been demonstrated that TGFb-related molecules are not
highly diffusible within the intact embryo (Reilly and Mel-tion exists between the potential for TGFb-3 to induce en-
docardial cell transformation in vitro and how long the tar- ton, 1996), a property which is inconsistent with a signal
that must traverse an extracellular matrix of 150-plus mmget endothelial cells had previously interacted in vivo with
the myocardium or its basement membrane. That endocar- separating the myocardium from its target endocardium
(Kitten et al., 1987). Rather, something else secreted by thedial cells must be ®rst activated by myocardial signaling in
order to respond to TGFb might partly explain why Potts myocardium is more likely needed to bring the endocar-
dium to a point where it can respond to TGFb (presumablyand Runyan (1989) were unable to induce mesenchyme for-
mation in the chick with TGFb-1 unless the endocardium secreted by activated endocardial cells). We have suggested
that such a myocardial factor may be an ES antigenwas cocultured with ventricular myocardium. The ®ndings
of Potts and Runyan (1989) are particularly important be- (Mjaatvedt et al., 1991; Rezeaee et al., 1993; Krug et al.,
1995) or some other factor enriched in the myocardium ofcause they af®rm a requirement for myocardial signaling
independent of that engendered by TGFb. These dataÐlike cushion-forming regions, e.g., bone morphogenetic protein
(Jones et al., 1991).that observed for the effects of TGFb-3 on stage 13 vs 14
culturesÐindicate TGFb cannot be the sole myocardial sig- Is the response of cultured AV endocardial cells to TGFb
actually mimicking an endogenous, in vivo step in the pro-nal needed to induce complete transformation of endocar-
dium to mesenchyme. Indeed, other observations suggest cess of cushion mesenchyme formation, or is it merely cul-
ture phenomenology? The likelihood for endocardial cellsTGFb is not likely to be even part of the myocardial signal.
First, to date no active form of a TGFb peptide has been responding in vivo to TGFb is supported by previous studies
which indicate that during the time required to go fromfound in the growth medium secreted by myocardial cells
nor has it been found in the adheron particulates secreted stage 13 to stage 15 in the embryo (when endocardial cells
begin to migrate), AV endocardial cells begin to expressin vivo into the basement membrane of the myocardium.
Yet, even in the absence of a TGF component, adherons TGFb-3 (Nakajima et al., 1994; Ramsdell et al., submitted).
Both the TGFb ligand and its receptors (Nakajima et al.,have been shown to be a source of proteins suf®cient to
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FIG. 7. Treatment of target AV endocardial cells with a TGFb-3 antibody in the presence of cocultured myocardial tissue. Stage 14 AV
explants containing myocardium plus endocardium attach to collagen gels [(A) surface view] and give rise to invasive mesenchyme
(arrowheads) which are detected beneath the plane of the monolayer [(B) deep view] in the presence of nonimmune goat IgG. Addition of
goat anti-TGFb-3 IgG results in endocardial cells which attach to the collagen gel [(C) surface view], but which are inhibited in migration
on top of the gel and which form little invasive mesenchyme [(D) deep view]. The inhibitory effect of the TGFb-3 antibody is overridden
by simultaneous addition of 10 ng/ml recombinant chicken TGFb-3 such that formation of invasive mesenchyme (arrowheads) is rescued
[(E) surface view, (F) deep view]. Bar, 100 mm.
1994; Brown et al., 1996) continue to be expressed on endo- to this question relates to the processing of TGFb. While
endocardial cells may begin expressing TGFb at stage 13/cardial cells migrating in vivo as free mesenchyme. Thus,
our present ®nding of TGFb-3 in MCCM is consistent with or 14, Ghosh and Brauer (1996) have shown that the pro-
cessing of latent TGFb into an active form does not occurin vivo evidence for the secretion of this growth factor.
Therefore, if AV endocardial/mesenchymal cells respond in until stage 15, exactly the point at which endocardial forma-
tion of mesenchyme becomes fully autonomous (Runyanvivo to TGFb, it is likely to be an autocrine response to
their own secretion. However, if TGFb is truly acting in an and Markwald, 1983). After stage 15, neither myocardial
coculture nor exogenous signals are required to initiate mes-autocrine mode, why must we add exogenous TGFb to stage
14 endocardial monolayers to induce their transformation enchyme formation. Thus, by adding exogenous TGFb to
stage 13 and 14 cultures, we most likely bypassed the timeto mesenchyme? Presumably, if some stage 13 and 14 endo-
cardial cells are expressing TGFb in response to prior myo- required for the cells to process their own latent TGFb, an
observation supported by the recent ®nding of Nakajima etcardial signaling (Figs. 6 and 8), they should form mesen-
chyme if left untreated. Yet, as shown in Fig. 2, only 20% al. (1997b).
Importantly, results obtained with MCCM and TGFb-3do so (and even less for stage 13). We suggest the resolution
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8637 / 6x29$$$$63 07-14-97 07:42:24 dba
72 Ramsdell and Markwald
can elicit mesenchyme migration in another appropriately
staged (stage 14) population of endocardial cells (Figs. 4 and
5). This raises the intriguing possibility that in vivo, in addi-
tion to an autocrine role to initiate or sustain cell migration,
secreted TGFb-3 might also feed back upon neighboring
endocardial cells to promote the onset of their migratory
behavior. Feedback of this type could serve to enhance or
amplify the process of mesenchyme formation originally
triggered by a myocardial signal. The actual purpose of myo-
cardial signaling may be to bring an endocardial cell to a
developmental status where it becomes competent to se-
FIG. 8. Quantitative summary of AV cocultures containing myo- crete a factor which can act both autocrinely to self-regulate
cardium plus endocardium treated with either control or TGFb-3 the ®nal steps of transformation and paracrinely to induce
antibody. Stages 13/ and 14 AV cocultures containing myocardium
similar transforming events in neighboring endocardialplus endocardium treated with either nonimmune IgG or a TGFb-
cells. Such an inductive interaction where target cells, in3 antibody as described for Fig. 6 were evaluated for the presence
turn, become signaling cells upon induction has been de-of invasive (seeded) mesenchyme following 24 hr of treatment. The
scribed historically as ``homogenetic induction'' (Spemann,results are expressed as averages {SD and were signi®cantly differ-
1938). With respect to cushion formation, such an inductiveent as evaluated by a x2 test for proportions (x2  26.63, P 
0.000001 for stage 13/; x2  17.14, P  0.0001 for stage 14). Stage mechanism could mean that myocardial signaling would
13/, n  19 (nonimmune IgG), n  18 (TGFb-3 antibody); stage not have to be sustained until all mesenchymal cell forma-
14, n  12 (nonimmune IgG), n  12 (TGFb-3 antibody).
antibodies indicate that the TGFb-3 secreted by trans-
forming cushion cells, like that of exogenously added
TGFb-3, is suf®cient to initiate endocardial cell migration.
The ability of TGFb-3 to elicit changes in morphology and
protein expression associated with a motile phenotype is
not unique to AV endocardial cells, but rather has also been
observed for other cell types (reviewed by Sporn and Rob-
erts, 1988; Miyazono et al., 1994). In a recent study, we
found that TGFb-3 increased expression of a-smooth mus-
cle actin in the migratory appendages of cultured cushion
endocardial cells (Nakajima et al., 1997a). Others have simi-
larly predicted or concluded that TGFb affects migratory
behavior required to form cushion mesenchyme (Potts and
Runyan, 1991; Brown et al., 1996; Ghosh and Brauer, 1996).
To that, we now propose that a relevant source of TGFb is
from the transforming endocardial/mesenchymal cells
themselves and that their secretion (and processing) of
TGFb-3 speci®cally is an inducible (target cell) response to
in vivo interaction with the myocardium.
Thus, two signaling pathways, myocardial and endocar-
dial/mesenchymal, are seemingly needed to bring endocar-
dial cells to a point where they can transform into mesen-
chyme. The data would suggest that the myocardial path-
way ®rst signals the activation of the endocardial pathway
FIG. 9. Expression of mesenchymal cell protein markers by cul-by some mechanism other than TGFb-3. Second, the endo-
tured AV endocardial cells. AV explants containing myocardiumcardial pathway signals invasive mesenchyme formation
plus endocardium treated with either control [(A) deep view ofthrough TGFb-3 functioning in an autocrine manner. Fi-
invaded mesenchyme] or TGFb-3 antibody [(B) surface view] asnally, there was no evidence that the two signaling path-
described for Fig. 7 were immuno¯uorescently dual labeled for a-
ways are functionally redundant. smooth muscle actin (FITC, green) and TGFb-3 (RITC, red). Or-
One further signi®cance of an ``endocardial signaling ange-yellow staining is indicative of colocalized immunoreactivity.
pathway'' suggested by the results obtained with MCCM The myocardium was removed from the TGFb-3 antibody-treated
and anti-TGFb antibodies is that TGFb-3 secreted by one culture after immunohistochemical labeling to facilitate viewing
of the endocardial monolayer. Bars, 100 mm.population of transforming endocardial/mesenchymal cells
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for nodal in the formation and maintenance of the primitivetion had been completed nor would each potential target
streak in the mouse. Development 120, 1919±1928.endothelial cell have to be directly activated by a myocar-
Delannet, M., and Duband, J.-L. (1992). Transforming growth fac-dial signaling molecule to initiate invasive migration.
tor-beta control of cell-substratum adhesion during avian neuralTGFb-3 is such a candidate homogenetic inducer: its ex-
crest cell emigration in vitro. Development 116, 275±287.pression is markedly enhanced after myocardial signaling
Eisenberg, L. M., and Markwald, R. R. (1995). Molecular regulation
(Nakajima et al., 1994) and, as shown in the present study, of atrioventricular valvuloseptal morphogenesis. Circ. Res. 77,
TGFb-3 secreted into MCCM promotes invasive migration. 1±6.
Identi®cation of TGFb-3 as a candidate autocrine/paracrine- Ghosh, S., and Brauer, P. R. (1996). Latent TGF-beta is present in
acting signal involved in endocardial cell migration and in- the extracellular matrix of embryonic hearts in situ. Dev. Dyn.
vasion in vitro will facilitate future studies of endocardial 205, 126±134.
Hamburger, V., and Hamilton, H. E. (1951). A series of normalcushion formation in vivo.
stages in the development of the chick embryo. J. Morphol. 88,The heart is not the only epithelial±mesenchymal trans-
49±92.formation in which a role for TGFb has been proposed.
Hay, E. D. (1995). An overview of epithelio-mesenchymal transfor-TGFb family members have been reported to mediate cell
mation. Acta. Anat. 154, 8±20.motility during gastrulation (Conlon et al., 1994) and neural
Huang, J.-X., Potts, J. D., Vincent, E. B., Weeks, D. L., and Runyan,crest cell emigration (Delannet and Duband, 1992; Basler
R. B. (1995). Mechanisms of cell transformation in the embryonic
et al., 1993). In these two systems as well as in the heart, heart. Ann. N. Y. Acad. Sci. 752, 317±330.
the TGFb-related proteins important for mesenchyme for- Icardo, J. M. (1989). Changes in endocardial cell morphology during
mation appear to be an autocrine mechanism to complete, development of the endocardial cushions. Anat. Embryol. 179,
but not actually activate, the transformation process (Basler 443±448.
et al., 1993; Brauer and Yee, 1993). Together, these ®ndings Isokawa, K., Rezaee, M., Wunsch, A. M., Markwald, R. R., and
Krug, E. L. (1994). Identi®cation of transferrin as one of multipleraise the possibility that epithelial±mesenchymal transfor-
EDTA-extractable extracellular proteins involved in early chickmations occuring in diverse systems during vertebrate em-
heart morphogenesis. J. Cell. Biochem. 55, 1±12.bryogenesis may be regulated through a common, progres-
Jones, C. M., Lyons, K. M., and Hogan, B. L. (1991). Involvement ofsive process involving TGFb-mediated autocrine or para-
bone morphogenetic protein-4 (BMP-4) and Vgr-1 in morphogene-crine signaling.
sis and neurogenesis in the mouse. Development 111, 531±542.
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